Diffusion Study on Patients With Osteosarcoma

The Role of PET/MRI in Predicting the Outcome of Definitive Chemoradiotherapy for Esophageal Cancer Patients

NCT05855278 ·Status: COMPLETED ·Phase: NA

PET/MRI in Predicting the Outcome of Neoadjuvant Chemoradiotherapy With Esophagectomy in Esophageal Cancer Patients

NCT05855291 ·Status: COMPLETED ·Phase: NA

Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma

NCT01411579 ·Status: COMPLETED

Evaluation of OE-MRI in Patients With H&N Cancer

NCT04724096 ·Status: COMPLETED

Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy

NCT01269970 ·Status: COMPLETED

Tumor Metabolism of Lung Cancer in Patients Who Underwent Percutaneous Radiation Measured With F-18-FDG-PET

NCT00180154 ·Status: COMPLETED

18F-FSPG PET/CT as a Non-Invasive Imaging Biomarker for Treatment Response to Chemoradiation in Esophageal Cancer

NCT06549413 ·Status: ACTIVE_NOT_RECRUITING

The Prediction Using Diffusion MRI of the Response Evaluation in BRPC in NAT.

NCT02777463 ·Status: COMPLETED

Dynamic Contrast Enhanced MRI(DCE-MRI)of Bone Tumors

NCT00598741 ·Status: COMPLETED ·Phase: NA

PET Imaging-guided Chemoradiotherapy in Esophageal Squamous Cell Carcinoma

NCT03791905 ·Status: UNKNOWN ·Phase: PHASE2

Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Diagnosing Osteoradionecrosis in Patients With Head and Neck Cancer That Is Primary, Has Come Back, or Has Spread to Other Places in the Body

NCT03145077 ·Status: RECRUITING ·Phase: NA

Differentiation of Bone Sarcomas and Osteomyelitis With Ferumoxytol-Enhanced MRI

NCT01336803 ·Status: COMPLETED ·Phase: PHASE2

Early Assessment of the Response to Neo-adjuvant Chemotherapy in Breast Cancer Patients With FDG-PET

NCT00904410 ·Status: COMPLETED ·Phase: PHASE4

Diffusion-weighted Imaging Study in Cancer of the Ovary

NCT01505829 ·Status: COMPLETED

Double-bed SPECT/CT for Bone Scintigraphy in Initial Staging of Cancer Patients

NCT03353090 ·Status: COMPLETED

An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas

NCT05560009 ·Status: COMPLETED

Optimized Diffusion-Weighted Imaging for the Evaluation of Post-Treatment Squamous Cell Carcinoma in the Neck: Comparative Study With FDG PET/CT

NCT04685798 ·Status: TERMINATED ·Phase: NA

Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer

NCT06232122 ·Status: RECRUITING ·Phase: NA

18F-FTC-146 PET/CT in Newly-Diagnosed Osteosarcoma

NCT04365660 ·Status: TERMINATED ·Phase: PHASE2

Utility of Perfusion MRI to Detect Radiation Necrosis in Patients With Brain Metastases

NCT03680144 ·Status: COMPLETED ·Phase: NA

18F-FDG PET/CT Versus 18F-FDG PET/MRI in Detecting Locoregional Recurrence 3 Months After CRT in Head and Neck SCC

NCT04196985 ·Status: UNKNOWN ·Phase: NA

Non-invasive MRI Subclassification of Heptocellular Carcinoma - HepCaSt-Study

NCT05202015 ·Status: UNKNOWN

Response of Brain Metastases After Gamma-Knife Radiosurgery Using Dynamic Susceptibility-weighted Contrast-enhanced Perfusion Magnetic Resonance Imaging

NCT02311556 ·Status: COMPLETED ·Phase: PHASE1

PET-CT Based Radiotherapy in Esophageal Cancer Patients

NCT01156831 ·Status: COMPLETED

Prediction of Response to 2nd-line Hormone Therapy by FES CT/PET in Patients With Metastatic Breast Cancer

NCT03442504 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA